Literature DB >> 19717726

Transforming growth factor-beta signaling in hypertensive remodeling of porcine aorta.

Natasa Popovic1, Eric A Bridenbaugh, Jessemy D Neiger, Jin-Jia Hu, Marina Vannucci, Qianxing Mo, Jerome Trzeciakowski, Matthew W Miller, Theresa W Fossum, Jay D Humphrey, Emily Wilson.   

Abstract

A porcine aortic coarctation model was used to examine regulation of gene expression in early hypertensive vascular remodeling. Aortic segments were collected proximal (high pressure) and distal (low pressure) to the coarctation after 2 wk of sustained hypertension (mean arterial pressure>150 mmHg). Porcine 10K oligoarrays used for gene expression profiling of the two regions of aorta revealed downregulation of cytoskeletal and upregulation of extracellular region genes relative to the whole genome. A genomic database search for transforming growth factor-beta (TGF-beta) control elements showed that 19% of the genes that changed expression due to hypertension contained putative TGF-beta control elements. Real-time RT-PCR and microarray analysis showed no change in expression of TGF-beta1, TGF-beta2, TGF-beta3, or bone morphogenetic proteins-2 and -4, yet immunohistochemical staining for phosphorylated SMAD2, an indicator of TGF-beta signaling, and for phosphorylated SMAD1/5/8, an indicator of signaling through the bone morphogenetic proteins, showed the highest percentage of positively stained cells in the proximal aortic segments of occluded animals. For TGF-beta signaling, this increase was significantly different than for sham-operated controls. Western blot analysis showed no difference in total TGF-beta1 protein levels with respect to treatment or aortic segment. Immunohistochemistry showed that the protein levels of latency-associated peptide was decreased in proximal segments of occluded animals. Collectively, these results suggest that activation of TGF-beta, but not altered expression, may be a major mechanism regulating early hypertensive vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19717726      PMCID: PMC2793137          DOI: 10.1152/ajpheart.01015.2008

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  35 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Fundamentals of experimental design for cDNA microarrays.

Authors:  Gary A Churchill
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 3.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

Review 4.  Integrin-mediated activation of latent transforming growth factor beta.

Authors:  Dean Sheppard
Journal:  Cancer Metastasis Rev       Date:  2005-09       Impact factor: 9.264

5.  Endothelin-1, via ETA receptor and independently of transforming growth factor-beta, increases the connective tissue growth factor in vascular smooth muscle cells.

Authors:  Juan Rodriguez-Vita; Marta Ruiz-Ortega; Mónica Rupérez; Vanessa Esteban; Elsa Sanchez-López; Juan José Plaza; Jesús Egido
Journal:  Circ Res       Date:  2005-06-23       Impact factor: 17.367

6.  Latent transforming growth factor beta1 activation in situ: quantitative and functional evidence after low-dose gamma-irradiation.

Authors:  E J Ehrhart; P Segarini; M L Tsang; A G Carroll; M H Barcellos-Hoff
Journal:  FASEB J       Date:  1997-10       Impact factor: 5.191

7.  Time courses of growth and remodeling of porcine aortic media during hypertension: a quantitative immunohistochemical examination.

Authors:  Jin-Jia Hu; Andy Ambrus; Theresa W Fossum; Matthew W Miller; Jay D Humphrey; Emily Wilson
Journal:  J Histochem Cytochem       Date:  2007-12-10       Impact factor: 2.479

Review 8.  TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility.

Authors:  Bernhard Schmierer; Caroline S Hill
Journal:  Nat Rev Mol Cell Biol       Date:  2007-12       Impact factor: 94.444

9.  Essential role of Smad3 in angiotensin II-induced vascular fibrosis.

Authors:  Wansheng Wang; Xiao R Huang; Ellery Canlas; Kazuhiro Oka; Luan D Truong; Chuxia Deng; Neil A Bhowmick; Wenjun Ju; Erwin P Bottinger; Hui Y Lan
Journal:  Circ Res       Date:  2006-03-23       Impact factor: 17.367

10.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes.

Authors:  L P Sanford; I Ormsby; A C Gittenberger-de Groot; H Sariola; R Friedman; G P Boivin; E L Cardell; T Doetschman
Journal:  Development       Date:  1997-07       Impact factor: 6.868

View more
  8 in total

1.  Endoplasmic reticulum stress is involved in cardiac damage and vascular endothelial dysfunction in hypertensive mice.

Authors:  Modar Kassan; Maria Galán; Megan Partyka; Zubaida Saifudeen; Daniel Henrion; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04-26       Impact factor: 8.311

2.  Congestive heart failure: experimental model.

Authors:  Antonio Francesco Corno; Xue Cai; Caroline B Jones; Giuseppina Mondani; Mark R Boyett; Jonathan Charles Jarvis; George Hart
Journal:  Front Pediatr       Date:  2013-10-28       Impact factor: 3.418

3.  Epithelial cells are active participants in vocal fold wound healing: an in vivo animal model of injury.

Authors:  Ciara Leydon; Mitsuyoshi Imaizumi; Rebecca S Bartlett; Sarah F Wang; Susan L Thibeault
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

4.  Acetyl-11-Keto-β-Boswellic Acid Attenuates Prooxidant and Profibrotic Mechanisms Involving Transforming Growth Factor-β1, and Improves Vascular Remodeling in Spontaneously Hypertensive Rats.

Authors:  Peijin Shang; Wenxing Liu; Tianlong Liu; Yikai Zhang; Fei Mu; Zhihui Zhu; Lingfei Liang; Xiaohu Zhai; Yi Ding; Yuwen Li; Aidong Wen
Journal:  Sci Rep       Date:  2016-12-23       Impact factor: 4.379

5.  Telmisartan improves vascular remodeling through ameliorating prooxidant and profibrotic mechanisms in hypertension via the involvement of transforming growth factor-β1.

Authors:  Peijin Shang; Tianlong Liu; Wenxing Liu; Yuwen Li; Fang Dou; Yikai Zhang; Lijuan Sun; Tiejun Zhang; Zhihui Zhu; Fei Mu; Yi Ding; Aidong Wen
Journal:  Mol Med Rep       Date:  2017-08-04       Impact factor: 2.952

6.  Transforming Growth Factor-β1 Modulates the Expression of Syndecan-4 in Cultured Vascular Endothelial Cells in a Biphasic Manner.

Authors:  Takato Hara; Eiko Yoshida; Yasuyuki Fujiwara; Chika Yamamoto; Toshiyuki Kaji
Journal:  J Cell Biochem       Date:  2017-04-10       Impact factor: 4.429

Review 7.  Endoplasmic reticulum stress and Nox-mediated reactive oxygen species signaling in the peripheral vasculature: potential role in hypertension.

Authors:  Celio X C Santos; Adam A Nabeebaccus; Ajay M Shah; Livia L Camargo; Sidney V Filho; Lucia R Lopes
Journal:  Antioxid Redox Signal       Date:  2013-05-01       Impact factor: 8.401

8.  Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties.

Authors:  Jelica Grujić-Milanović; Vesna Jaćević; Zoran Miloradović; Djurdjica Jovović; Ivica Milosavljević; Sladjan D Milanović; Nevena Mihailović-Stanojević
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.